Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-25 @ 1:25 PM
NCT ID:
NCT02210559
Group ID:
EG000
Title:
Arm A: Gemcitabine Plus Nab-paclitaxel + Pamrevlumab (G/NP+P)
Description:
Participants received gemcitabine at 1000 mg/m\^2 plus nab-paclitaxel at 125 mg/m\^2 by IV infusion on Days 1, 8, and 15 of each cycle. Participants received pamrevlumab at 35 mg/kg by IV infusion on Days 1 and 15 of each cycle. An additional dose of pamrevlumab was given on Day 8 of the first cycle. Participants received a total of up to six 28-day cycles of treatment.
Deaths Number Affected:
17
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
24
Other Number Affected:
24
Other Number At Risk:
24
Study:
NCT02210559
Results Section:
NCT02210559
Adverse Events Module:
NCT02210559